How is the Immatics N.V today?

The Immatics N.V today is trading in the green, up by 2.38% at 5.59.

How has Immatics N.V performed historically?

The Immatics N.V is currently trading up 2.38% on an intraday basis in the past week the index fell -4.44%. The index has been up 19.44% in the past quarter and fell -53.42% in the past year. You can view this in the overview section.

What is Immatics N.V Annual Revenue?

Immatics N.V Annual Revenue rose 188.6%, in the last year to $155.84 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Immatics N.V Annual Net Profit?

Immatics N.V Annual Net Profit rose 116.08% in the last year to $15.22 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Immatics N.V Price to Earning Ratio?

Immatics N.V Price to Earning Ratio is -27.11, which is negative.

What is Immatics N.V Stock Price?

Immatics N.V Stock Price fell 53.42% and underperformed its sector by 104.41% in the past year.

What is Immatics N.V Quarterly Revenue?

Immatics N.V Quarterly Revenue fell 38.61% YoY to $18.58 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Immatics N.V Quarterly Net profit?

Immatics N.V Quarterly Net profit fell 1,679.24% YoY to $39.86 M. Its sector's average net profit growth YoY for the quarter was -236.03%.

What is Immatics N.V Debt to Equity Ratio?

Immatics N.V Debt to Equity Ratio of 0.03 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Immatics N.V Return on Equity(ROE)?

Immatics N.V Return on Equity(ROE) for the last financial year was 3.84%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Immatics N.V Mutual Fund Holding?

Immatics N.V Mutual Fund Holding decreased by 1.4% in the last quarter to 22.15.

What is Immatics N.V Interest Coverage Ratio?

Immatics N.V Interest Coverage Ratio is 25.09, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Immatics N.V Institutional Holding?

Immatics N.V Institutional Holding decreased by 0.02% in the last quarter to 74.36.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
IMMATICS N.V

Immatics N.V XNAS: IMTX

Immatics N.V Live Share Price Today, Share Analysis and Chart

Name: Immatics N.V: Is Infosys Ltd. worth buying?
Item: Immatics N.V
Rating: 1.915277625
Author: Trendlyne DVM scores

Expensive Performer

about

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceu...

5.59 0.13 (2.38%)

57.30% Fall from 52W High

767.2K

XNAS Volume

XNAS 26 Jun, 2025 3:56 PM (EDT)

Medium Financial Strength

44.4 / 100

Expensive Valuation

22.3 / 100

Technically Neutral

42.0 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

1Yr Price target upside is 156%

6 analysts

Immatics N.V Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Immatics N.V Live Share Price Today, Share Analysis and Chart

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceu...

57.30% Fall from 52W High

Immatics N.V Live Price Chart

Immatics N.V FAQ

How is Immatics N.V today?

Immatics N.V today is trading in the green, and is up by 2.38% at 5.59.

How has Immatics N.V performed historically?

Immatics N.V is currently trading up 2.38% on an intraday basis. In the past week the stock fell -4.44%. stock has been up 19.44% in the past quarter and fell -53.42% in the past year. You can view this in the overview section.